These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32153123)

  • 41. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LncRNA MEG8 promotes tumor progression of non-small cell lung cancer via regulating miR-107/CDK6 axis.
    Liu Y; Li L; Shang P; Song X
    Anticancer Drugs; 2020 Nov; 31(10):1065-1073. PubMed ID: 32649368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
    Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
    Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-374b mediates the initiation of non-small cell lung cancer by regulating ITGB1 and p53 expressions.
    Zhao M; Tong C; Hao Z; Zhao R; Wang L
    Thorac Cancer; 2020 Jun; 11(6):1670-1678. PubMed ID: 32364676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SOX2-induced upregulation of lncRNA LINC01561 promotes non-small-cell lung carcinoma progression by sponging miR-760 to modulate SHCBP1 expression.
    Gao W; Qi CQ; Feng MG; Yang P; Liu L; Sun SH
    J Cell Physiol; 2020 Oct; 235(10):6684-6696. PubMed ID: 32003010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
    Zhao M; Ma W; Ma C
    Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A SNP-mediated lncRNA (LOC146880) and microRNA (miR-539-5p) interaction and its potential impact on the NSCLC risk.
    Feng T; Feng N; Zhu T; Li Q; Zhang Q; Wang Y; Gao M; Zhou B; Yu H; Zheng M; Qian B
    J Exp Clin Cancer Res; 2020 Aug; 39(1):157. PubMed ID: 32795333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
    Liu L; Chen Y; Li Q; Duan P
    J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LncRNA FENDRR suppresses the progression of NSCLC via regulating miR-761/TIMP2 axis.
    Zhang G; Wang Q; Zhang X; Ding Z; Liu R
    Biomed Pharmacother; 2019 Oct; 118():109309. PubMed ID: 31545237
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Downregulation of LINC00665 confers decreased cell proliferation and invasion via the miR-138-5p/E2F3 signaling pathway in NSCLC.
    Wang H; Wang L; Zhang S; Xu Z; Zhang G
    Biomed Pharmacother; 2020 Jul; 127():110214. PubMed ID: 32403047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SNHG20 knockdown suppresses proliferation, migration and invasion, and promotes apoptosis in non-small cell lung cancer through acting as a miR-154 sponge.
    Lingling J; Xiangao J; Guiqing H; Jichan S; Feifei S; Haiyan Z
    Biomed Pharmacother; 2019 Apr; 112():108648. PubMed ID: 30780105
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3.
    Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T
    IUBMB Life; 2018 Jun; 70(6):536-546. PubMed ID: 29707897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LncRNA PRNCR1 interacts with HEY2 to abolish miR-448-mediated growth inhibition in non-small cell lung cancer.
    Cheng D; Bao C; Zhang X; Lin X; Huang H; Zhao L
    Biomed Pharmacother; 2018 Nov; 107():1540-1547. PubMed ID: 30257372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p.
    Jing H; Xia H; Qian M; Lv X
    Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Upregulation of Long Noncoding RNA GAS5 Inhibits Lung Cancer Cell Proliferation and Metastasis via miR-205/PTEN Axis.
    Dong L; Li G; Li Y; Zhu Z
    Med Sci Monit; 2019 Mar; 25():2311-2319. PubMed ID: 30926767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long Noncoding RNA GAS5 Suppresses Tumorigenesis by Inhibiting miR-23a Expression in Non-Small Cell Lung Cancer.
    Mei Y; Si J; Wang Y; Huang Z; Zhu H; Feng S; Wu X; Wu L
    Oncol Res; 2017 Jul; 25(6):1027-1037. PubMed ID: 28059053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Downregulation of miR-200c Promotes Lactate Dehydrogenase A Expression and Non-Small Cell Lung Cancer Progression.
    Lei W; Kang W; Nan Y; Lei Z; Zhongdong L; Demin L; Lei S; Hairong H
    Oncol Res; 2018 Aug; 26(7):1015-1022. PubMed ID: 29321091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long noncoding RNA SNHG14 exerts oncogenic functions in lung adenocarcinoma through acting as a sponge to miR-613.
    Xu ZN; Wang ZX; Xu L; Yu HX; Chao K; Yang LL; Han XL; Sun HB
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10810-10817. PubMed ID: 31858549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.